InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
HKSP | Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in... | 2021 | Cancers (Basel). | Mann J.E. et al. | DOI: 10.3390/cancers13194782 |
HKMT | Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in... | 2021 | Cancers (Basel). | Mann J.E. et al. | DOI: 10.3390/cancers13194782 |
HKSA | Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in... | 2021 | Cancers (Basel). | Mann J.E. et al. | DOI: 10.3390/cancers13194782 |
HKSP | cGAS-STING and MyD88 Pathways Synergize in Ly6C hi Monocyte to Promote Strept... | 2021 | Front Immunol. | Patel S. et al. | DOI: 10.3389/fimmu.2021.699702 |
FLA-ST (Standard or Ultrapure) | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
HKSP | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
LTA-SA | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
LPS-EB (LPS from E. coli O111:B4) | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
ODN 2216 - TLR9 ligand | A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... | 2021 | PLoS One | Maguire P.M. et al. | DOI: 10.1371/journal.pone.0258261 |
Plasmocin® - Mycoplasma Elimination Reagent | Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positiv... | 2021 | Commun Biol. | Laliotis G.I. et al. | DOI: 10.1038/s42003-021-02668-z |
pFUSE-CHIg-hG1 | HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... | 2021 | Commun Biol. | Tanaka H. et al. | DOI: 10.1038/s42003-021-02671-4 |
pFUSE2-CLIg-hK | HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... | 2021 | Commun Biol. | Tanaka H. et al. | DOI: 10.1038/s42003-021-02671-4 |
Puromycin | A role for AKT1 in nonsense-mediated mRNA decay. | 2021 | Nucleic Acids Res. | Palma M. et al. | DOI: 10.1093/nar/gkab882 |
pVITRO2-MCS | Identification and Characterization of a Novel Single Domain Antibody Against... | 2021 | Virol Sin. | Wang R. et al. | DOI: 10.1007/s12250-021-00454-z |
Poly(I:C) (HMW) VacciGrade™ | A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irra... | 2021 | Virol J. | Sabbaghi A. et al. | DOI: 10.1186/s12985-021-01672-3 |
Anti-hTLR4 Neutralizing mAb | The soluble cytoplasmic tail of CD45 regulates T cell activation via TLR4 sig... | 2021 | Eur J Immunol. | Puck A. et al. | DOI: 10.1002/eji.202149227 |
QUANTI-Luc™: Luciferase Detection Reagent | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
293-Dual™ hSTING-R232 Cells | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
QUANTI-Blue™ | Next generation of tumor-activating type I IFN enhances anti-tumor immune res... | 2021 | Nat Commun. | Cao X. et al. | DOI: 10.1038/s41467-021-26112-2 |
AddaVax™ | Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-ne... | 2021 | J Exp Med | Shinnakasu R. et al. | DOI: 10.1084/jem.20211003 |